Aims To analyze the serum lipid and inflammatory biomarker profile in the early insulin resistance (e-IR). Methods Cross-sectional study of 5943 adults without diabetes, stratified into no IR group (C-peptide \third tertile and glucose \100 mg/dL), e-IR group (C-peptide Cthird tertile and glucose \100 mg/dL) and advanced IR group (glucose C100 mg/dL). Results E-IR showed significant differences with no IR in the serum concentration of triglycerides (P \ 0.001), HDL cholesterol (P \ 0.001), LDL cholesterol (P \ 0.001), sCD40L (P \ 0.001), C-reactive protein (P \ 0.004), leptin (P \ 0.001) and adiponectin (P \ 0.001). Adjusting for age, gender and abdominal obesity, corroborated the association of e-IR with highest quintile of triglycerides Conclusions Euglycemic patients with e-IR present an unfavorable serum lipid and inflammatory biomarker profile. Measuring C-peptide in euglycemic patients with elevated triglycerides identifies e-IR.
Introduction
Type 2 diabetes mellitus is currently believed to be the result of insulin resistance (IR) combined with the loss of pancreatic b-cell mass and functioning [1] . Insulin resistance appears early, before glucose intolerance becomes detectable, and involves lipid and protein metabolism imbalances along with mineral and electrolyte alterations [2] [3] [4] . The IR state is seen together with visceral obesity [5] , ectopic fat deposits in the muscle, liver and pancreatic islets [6, 7] , hypertension, dyslipidemia, endothelial dysfunction, elevated levels of plasminogen activator inhibitor-1 (PAI-1) and ferritin [8, 9] . In addition, the accumulation of adipose tissue increases the secretion of cytokines and adipokines such as tumor necrosis factor-alpha, interleukin-6, leptin and resistin, among others, which can be cytotoxic for b-cells [10] . These alterations give rise to an inflammatory Managed by Antonio Secchi. environment with overexposure to acute phase proteins such as C-reactive protein (CRP) [11] . As IR progresses, hyperglycemia can ensue, leading to the production of oxygen reactive species which further potentiate inflammation [12] . When diabetes develops, there are numerous inflammatory cytokines capable of detecting IR and predict the fasting plasma glucose [13] .
Because of these alterations, patients who develop type 2 diabetes mellitus have an increased risk of developing cardiovascular disease, which in turn may involve severe complications including myocardial infarction and stroke [14] . However, the increased cardiovascular morbidity and mortality associated with IR is also present even before type 2 diabetes mellitus per se appears [15] . This makes IR itself a good predictor of the cardiovascular events noted above [16] . In fact, earlier work has found that by classifying the population according to serum C-peptide and glucose concentration, it is possible to identify the early stage of IR, when the risk of cardiovascular disease is already elevated in the absence of hyperglycemia [17] .
The aim of this study was to determine the serum lipid and inflammatory biomarker profile in a sample of people in the general population who do not have type 2 diabetes mellitus and whose serum glucose concentration is within the normal range, but who do have early IR.
Methods

Participants and design
The participants in this cross-sectional study were drawn from the CDC de Canarias cohort study. (The CDC acronym stands from Cardiovascular, Diabetes and Cancer.) Members of this cohort were randomly chosen during the years 2000-2005 from the general population of the Canary Islands (Spain) and ranged in age from 18 to 75 years. The methodology has been reported previously [18] . All participants recruited for the present analysis (n = 6729) were interviewed with the aid of a questionnaire designed to record information on their health-related antecedents (available at http://www. cdcdecanarias.org). In addition, all underwent physical examination to record anthropometric data and vital signs, and all provided a sample of venous blood after abstaining from food or drink for at least 10 h. Blood samples were centrifuged in situ at room temperature and 2000 rpm for 10 min and transported daily to the laboratory. This study was approved by the Bioethics Committee of Nuestra Señora de la Candelaria University Hospital, and all participants provided their informed consent in writing.
Variables
Serum glucose and lipid concentrations (triglycerides, total and high-density lipoprotein [HDL] cholesterol) were determined within 24 h after the blood sample was obtained and are reported here in mg/dL. Low-density lipoprotein (LDL) cholesterol was calculated with Friedewald's formula (excluding cases with triglycerides [300 mg/dL), and non-HDL cholesterol was recorded by subtracting HDL cholesterol from total cholesterol. Serum samples were stored at -80°C, and an aliquot was thawed and used to measure C-peptide (Biosource Ò , ng/mL) and resistin (Bio-Vendor Ò , ng/mL) with enzyme immunoanalysis techniques for the entire study population. A subset of randomly selected samples from a smaller number of individuals for the DARIOS Inflammatory Study [19] was used to determine insulin, leptin, PAI-1 and adiponectin concentrations with Luminex xMAP assays, CRP with a highly sensitive immunoturbidimetric assay (HORIBA-ABX Diagnostics) and soluble CD40 ligand (sCD40L) with an enzyme-linked immunosorbent assay.
Abdominal obesity was defined as a waist/height ratio of C0.55 [20] . Individuals with type 2 diabetes mellitus were excluded if they stated having the disease and were taking anti-diabetes medication, or if they were unaware of having the disease but had a fasting serum glucose concentration of C126 mg/dL. In these cases, a second glucose measurement was taken to verify the result.
To identify participants with IR, serum C-peptide and glucose concentrations were considered [17] , and C-peptide values in the upper tertile (T 3 ) were assumed to indicate exposure to elevated levels [21] [22] [23] . The population was classified into three IR groups: Group 1 (individuals with no IR: blood glucose \100 mg/dL and C-peptide \T 3 ), Group 2 (individuals with early IR: blood glucose \100 mg/dL and C-peptide CT 3 ) and Group 3 (individuals with advanced IR: hyperglycemia defined as serum glucose concentration [100 mg/dL after a 10-h fast).
Statistical analysis
Normally distributed variables are reported as summary statistics (mean ± SD); log natural transformation (LN) was used when needed to approximate the variable to the normal distribution. To compare mean values for the three IR groups, analysis of variance was used, with the Bonferroni test for post hoc comparisons. For variables that failed to approximate a normal distribution, the nonparametric Kruskal-Wallis test was used, and we show the median values together with 25th and 75th percentiles.
Categorical variables are reported as relative frequencies and absolute frequencies for each category. Chi-square test was used to compare proportions between groups.
The associations identified with bivariate analysis between IR categories and biomarker results were adjusted for age, gender and abdominal obesity with multivariate models for ordinal regression and multinomial logistic regression. For ordinal regression models, each biomarker (LN) was used as an independent continuous variable, and the three IR categories were used as a dependent ordinal variable. Goodness of fit was determined, and regression coefficients were calculated with 95 % confidence intervals (95 % CIs) and statistical significance. For multinomial models, the independent variable (biomarker) was categorized in quintiles to estimate the risk (odds ratio, OR), in each quintile, of early or advanced IR compared to the first quintile, used here as the reference category. Goodness of fit was determined, and we show the OR (95 % CI) and statistical significance for the fourth and fifth quintiles of each biomarker. The differences in risk of early and advanced IR across quintiles were plotted for each biomarker, and the significance of the trends in risk was calculated. All analyses were done with SPSSÓ version 21 software in Spanish.
Results
After persons with diabetes were excluded, the final study sample was 5943 individuals, of whom 3524 were included in the no IR group, 1321 in the early IR group and 1098 in the advanced IR group.
The distribution of values for the biomarkers and anthropometric indexes in each group are listed in Table 1 . Differences between groups were evident for serum glucose and C-peptide concentrations, but these variables were excluded from further analysis because the values were conditioned by how we defined our three IR groups. In the early IR group, the values for all biomarkers were significantly different compared to the no IR group except for resistin, PAI-1 and leptin in males. In the advanced IR group, the values for all biomarkers except PAI-1 were significantly different compared to the no IR group. In comparisons between the early IR and advanced IR groups, the only markers that were significantly different were serum lipids and resistin. For the anthropometric indexes, significant differences between groups were seen for mean age, proportion of males and abdominal obesity; the values in the early IR group were intermediate between those in the no IR and advanced IR groups.
In Table 2 , the ordinal models fitted to estimate the association between each biomarker and IR progression yielded significant regression coefficients (P \ 0.01) for insulin, triglycerides, HDL cholesterol, triglycerides/HDL cholesterol ratio, non-HDL cholesterol, CRP, adiponectin and sCD40L. The coefficients for leptin and resistin approached statistical significance, whereas the coefficients for LDL cholesterol and PAI-1 were not significant. Table 3 summarizes the estimated risks according to different multinomial logistic regression models for the association between each biomarker and IR category. For early IR, only LDL cholesterol and leptin showed no significant association, and for advanced IR, only leptin failed to show a significant association. Figure 1 shows the largest risks of early IR for each quintile of biomarker values according to the regression models. A significant trend toward increased risk was seen for values in the upper quintiles for triglycerides (P = 0.008), triglycerides/HDL cholesterol ratio (P = 0.009), non-HDL cholesterol (P = 0.011), LDL cholesterol (P = 0.003) and resistin (P = 0.009). A trend toward decreased risk was seen with increasing quintile values for HDL cholesterol (P = 0.012) and adiponectin (P = 0.047). Figure 2 shows the risks of advanced IR for each quintile of biomarker values according to the same regression models. A significant trend toward increased risk was seen in upper quintile values for triglycerides (P = 0.043), triglycerides/HDL cholesterol ratio (P = 0.022), non-HDL cholesterol (P = 0.001), LDL cholesterol (P = 0.011) and PAI-1 (P = 0.046), whereas the trend toward decreased risk approached significance for upper quintile values of HDL (P = 0.067), adiponectin (P = 0.077) and resistin (P = 0.077).
Discussion
Approximately 20 % of the general population without diabetes has early IR. These individuals are euglycemic but despite their normal blood sugar levels, they have high concentrations of C-peptide and insulin and a profile indicative of dyslipidemia (elevated values of triglycerides, LDL and non-HDL cholesterol and low concentrations of HDL cholesterol) and inflammation (elevated resistin, CRP and PAI-1, together with decreased adiponectin and sCD40L).
The population with early IR is on average 3 years older than the population without IR and is further characterized by a higher male sex ratio and a higher prevalence of abdominal obesity and elevated serum leptin levels. However, we found that the relationship of IR with lipids and cytokines is independent of obesity. The atherogenic lipid profile is a consequence of the diminished production of glucose by the liver during the early, euglycemic stage of IR, because when insulin production increases to limit the action of glucose-6-phosphatase and maintain normal levels of hepatic glucose production, an inevitable result is that glucokinase is stimulated, leading to the accumulation of fat in the liver and to triacylglycerol secretion [1] . When IR debuts, the pancreas has not yet been severely damaged. However, the elevated insulin levels along with equimolar C-peptide secretion have inflammatory effects in the vascular wall by favoring the accumulation of monocytes that stimulate increases in a number of cytokines [24, 25] . This may explain the increase we observed in PAI-1, CRP and resistin levels in the early stage of IR. The cross-sectional design of our study means that we are not able to establish what happens before IR becomes detectable, but we speculate that factors such as a diet rich in sugars and saturated fats along with a sedentary lifestyle may be responsible for the dyslipidemic profile and low adiponectin concentration that can be seen before obesity appears [26] . Given that persons with early IR have normal blood glucose levels, IR goes undetected in usual clinical practice, and there are no indications for treatment that might prevent it from progressing to advanced IR.
However, the lipid and cytokine profile we report here can be considered atherogenic and inflammatory, and in fact this population group is at elevated risk of coronary artery disease [17] . We use the term ''advanced IR'' to designate the presence of hyperglycemia regardless of C-peptide concentration. This population group makes up almost 20 % of the general population, and their clinical status is currently identified as prediabetes or altered basal glucose level. On average, this group is 10 years older than the population without IR and is characterized by a much higher male sex ratio, prevalence of abdominal obesity and a more markedly dyslipidemic profile (with significantly increased triglycerides, LDL and non-HDL cholesterol) compared to early IR. In contrast, insulin and C-peptide concentrations are lower in the advanced IR group, probably as a result of the progressive deterioration in pancreatic function after years of IR, and possibly related with the concomitant decrease in resistin. To our knowledge, this possible evolution of resistin, independently of obesity, with elevated levels in early IR followed by decreased levels in advanced IR, has not been described previously. This pattern of changes in resistin levels may account for the contradictory findings published regarding the relationship between this cytokine and IR [27] [28] [29] .
In the ordinal models, we found that the relationship between IR and different biomarkers approached a direct linear association for triglycerides, non-HDL cholesterol and CRP and an inverse association for HDL cholesterol, adiponectin and sCD40L. Although this was a cross-sectional study, these findings suggest that as IR progresses from the early stage toward the advanced stage, atherogenic and inflammatory biomarkers show a steady increase, while the concentrations of markers of a protective effect such as HDL cholesterol and adiponectin decrease. The linear associations for leptin and LDL cholesterol were not significant: Adjustment for abdominal obesity showed that both were dependent on this latter variable. The association between IR and resistin did not approach linearity: Resistin concentrations increased during early IR but decreased during advanced IR, as noted above.
In contrast to the ordinal models, the multinomial models showed the extent of the increase or decrease in risk of early or advanced IR according to biomarker values. Persons with values for triglycerides, triglyceride/HDL cholesterol ratio or PAI-1 in the upper two quintiles had a threefold greater risk of IR, and those with elevated CRP levels had a more than twofold greater risk, compared to the middle and lower two quintiles. In contrast, persons with HDL cholesterol or sCD40L values in the upper two quintiles had less than half the risk of IR, and those with adiponectin concentrations in the upper quintile had a risk of IR less than 20 % that of the middle or lower two quintiles. Of particular interest is our finding that the upper two quintiles of resistin values were associated with a 25 % increase in the risk of early IR, but with an almost 30 % decrease in the risk of advanced IR.
In terms of clinical practice, our results indicate that no single biomarker for IR performed better than values of triglycerides in the upper quintile ([136 mg/dL in women and [181 mg/dL in men). The estimated risk of IR of 3.88 estimated with triglyceride values was not surpassed by any of the lipids or cytokines analyzed here. Triglycerides and blood glucose values are habitually measured as part of screening tests used in primary care in developed countries, and it thus seems advisable to measure C-peptide concentration in middle-aged people with elevated triglycerides and normal blood glucose values. It has been proven that measurement of fasting plasma insulin (and therefore C-peptide) does provide a surrogate estimate of insulin action as good as calculation of HOMA-IR [30] . C-peptide is currently inexpensive to measure, and its values are much more stable than insulin given its twofold to fivefold longer half-life. This laboratory result may identify persons with early IR, whom we found to have an atherogenic and inflammatory biochemical profile and to be at greater risk of coronary artery disease [17] . To this population group belong women who after suffering a gestational diabetes present normal blood glucose levels, as they show a high IR prevalence [31] . The interventions found in the Diabetes Prevention Program [32] to be effective in improving advanced IR should be investigated to evaluate their usefulness in early IR. Our epidemiological study is consistent with the results of experimental studies in pointing to the potential benefits of preventing cardiovascular disease associated with type 2 diabetes mellitus before hyperglycemia appears [1] .
Quintiles of Biomarkers
The main limitation of this study is its cross-sectional design, which precluded investigating changes in IR and serum values with time, although a provisionally useful approximation was possible thanks to our categorization of IR as absent, early or advanced. Another important limitation was the low number of measures available for some biomarkers, which we were unable to study in greater detail due to budgetary restrictions. This may have diminished the power of some of our analyses. In this regard, because of the low number of participants in whom values were available for all biomarkers, we were unable to analyze the possible correlations among all markers in a single model. Among the strengths of our study are the large sample drawn from the general population without diabetes, and the fact that we were able to measure most variables in our entire sample.
We conclude that the population with early IR has an unfavorable lipid and inflammatory profile regardless of the presence or not of obesity, and independently of gender or age. Given that this population subgroup goes unidentified in the course of usual clinical practice, determining C-peptide concentration in patients with elevated triglyceride values may aid in detecting IR.
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